Balanced news tone
News Sentiment
CIZ sentiment intelligence
Cizzle Biotechnology Holdings Plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
25 relevant articles
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-5.1% over one week, -3.4% over four weeks, trend active, and materially above fair value.
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Earnings
79/100 classification
One-week reaction
-5.1%
Price reacting lower
Trend fit
Trend active
-3.4% over four weeks
Fair value
46.5%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
17
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stocktwits
Direct company coverage
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2026 17:14
- Source
- Stocktwits
Yorkshire Post
Direct company coverage
Cizzle Biotechnology: York firm sees early stage lung cancer test accredited in US
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 10:45
- Source
- Yorkshire Post
TradingView
Direct company coverage
REG - Cizzle Biotechnology - CIZ1B Test Approved For Clinical Use in USA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 06:00
- Source
- TradingView
Investing.com UK
Direct company coverage
Cizzle Biotechnology receives U.S. patent for lung cancer test By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Investing.com UK
simplywall.st
Direct company coverage
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Investing.com
Direct company coverage
Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing.com
TradingView
Direct company coverage
PDS Biotechnology Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- TradingView
simplywall.st
Direct company coverage
Is Sana Biotechnology’s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
marketscreener.com
Direct company coverage
Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- marketscreener.com
simplywall.st
Direct company coverage
Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
marketscreener.com
Direct company coverage
Cizzle Biotechnology Holdings Plc Auditor Raises 'Going Concern' Doubt
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 29 Apr 2026 07:00
- Source
- marketscreener.com
Market source
Direct company coverage
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
Kavout
Direct company coverage
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Feb 2026 09:53
- Source
- Kavout
TIKR.com
Direct company coverage
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Feb 2026 08:00
- Source
- TIKR.com
Barron's
Direct company coverage
These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Market source
Direct company coverage
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Feb 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Avecho Biotechnology First Half 2025 Earnings: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2024)
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 31 Aug 2025 07:00
- Source
- simplywall.st
London South East
Direct company coverage
Cizzle Biotech Level 2 Share Data. CIZ Order Book - See market maker prices.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2023 21:16
- Source
- London South East
London South East
Direct company coverage
Cizzle Biotech Live Share Prices and Trades. CIZ Live Streaming Share Prices.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2023 21:16
- Source
- London South East
TradingView
Direct company coverage
CIZ Stock Price and Chart — LSE:CIZ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2021 17:23
- Source
- TradingView